Currently, the diagnosis of breast cancer classification is mainly through immunohistochemistry (IHC), namely, diagnosis by the expression of four markers, ER (oestrogen receptor), PR (progestin receptor), HER2 gene (human epidermal growth factor receptor 2) and Ki-67 protein (proliferating cell nuclear antigen). This evidence concerns the gene ERBB2 and breast cancer.